Literature DB >> 20601619

Pharmacoresistant epilepsy: from pathogenesis to current and emerging therapies.

Sandipan Pati1, Andreas V Alexopoulos.   

Abstract

Almost one-third of people with epilepsy continue to have seizures despite appropriate antiepileptic drug treatment, placing them at considerable risk of cognitive and psychosocial dysfunction and death. We recommend early referral to an epilepsy center when seizures are difficult to control.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20601619     DOI： 10.3949/ccjm.77a.09061

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  15 in total

1.  Neurological autoantibodies in drug-resistant epilepsy of unknown cause.

Authors:  Mehmet Tecellioglu; Ozden Kamisli; Suat Kamisli; Fatma Ebru Yucel; Cemal Ozcan
Journal:  Ir J Med Sci       Date:  2018-03-09       Impact factor: 1.568

2.  Spectrofluorimetric Determination of Topiramate and Levetiracetam as Single Components in Tablet Formulations and in Human Plasma and Simultaneous Fourth Derivative Synchronous Fluorescence Determination of their Co-Adminstered Mixture in Human Plasma.

Authors:  A F El-Yazbi; M M Wagih; F Ibrahim; M A Barary
Journal:  J Fluoresc       Date:  2016-05-04       Impact factor: 2.217

3.  The protective effect of myo-inositol on hippocamal cell loss and structural alterations in neurons and synapses triggered by kainic acid-induced status epilepticus.

Authors:  Nato Kotaria; Maia Kiladze; Mzia G Zhvania; Nadezhda J Japaridze; Tamar Bikashvili; Revaz O Solomonia; Tamar Bolkvadze
Journal:  Cell Mol Neurobiol       Date:  2013-04-09       Impact factor: 5.046

4.  Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine.

Authors:  Vincenzo Barrese; Francesco Miceli; Maria Virginia Soldovieri; Paolo Ambrosino; Fabio Arturo Iannotti; Maria Roberta Cilio; Maurizio Taglialatela
Journal:  Clin Pharmacol       Date:  2010-12-07

Review 5.  Pharmacoresistant Epilepsy: A Current Update on Non-Conventional Pharmacological and Non-Pharmacological Interventions.

Authors:  Arun Kumar Sharma; Ekta Rani; Abdul Waheed; Satyendra K Rajput
Journal:  J Epilepsy Res       Date:  2015-06-30

6.  Failure of antiepileptic drugs in controlling seizures in epilepsy: What do we do next?

Authors:  Brahyan Galindo-Mendez; Luis C Mayor; Fernando Velandia-Hurtado; Carlos Calderon-Ospina
Journal:  Epilepsy Behav Case Rep       Date:  2015-05-28

7.  Metabolomics As a Tool for the Characterization of Drug-Resistant Epilepsy.

Authors:  Federica Murgia; Antonella Muroni; Monica Puligheddu; Lorenzo Polizzi; Luigi Barberini; Gianni Orofino; Paolo Solla; Simone Poddighe; Francesco Del Carratore; Julian L Griffin; Luigi Atzori; Francesco Marrosu
Journal:  Front Neurol       Date:  2017-09-04       Impact factor: 4.003

Review 8.  The Role of Magnesium in Neurological Disorders.

Authors:  Anna E Kirkland; Gabrielle L Sarlo; Kathleen F Holton
Journal:  Nutrients       Date:  2018-06-06       Impact factor: 5.717

9.  Atomic basis for therapeutic activation of neuronal potassium channels.

Authors:  Robin Y Kim; Michael C Yau; Jason D Galpin; Guiscard Seebohm; Christopher A Ahern; Stephan A Pless; Harley T Kurata
Journal:  Nat Commun       Date:  2015-09-03       Impact factor: 14.919

10.  Electrophoretic drug delivery for seizure control.

Authors:  Christopher M Proctor; Andrea Slézia; Attila Kaszas; Antoine Ghestem; Isabel Del Agua; Anna-Maria Pappa; Christophe Bernard; Adam Williamson; George G Malliaras
Journal:  Sci Adv       Date:  2018-08-29       Impact factor: 14.136
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.